Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$35,149,119
+$11,926,774 QoQ
Shares Held
273,534
+41.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#392
of 3,768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $371,290,075 across 10 Drug Manufacturers - General names. MRK ranks #5 (9.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
90,318 | $108,330,127 | |
| 2 | JNJ |
Johnson & Johnson
|
265,811 | $67,508,019 | |
| 3 | ABBV |
AbbVie Inc.
|
206,756 | $52,028,079 | |
| 4 | AMGN |
Amgen Inc
|
109,431 | $39,627,153 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
273,534 | $35,149,119 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
264,468 | $33,412,887 | |
| 7 | PFE |
Pfizer Inc
|
635,140 | $15,294,171 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
228,360 | $13,158,103 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,149,119 | 273,534 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,222,345 | 193,053 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $28,380,201 | 269,620 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $23,487,642 | 279,848 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,245,119 | 268,382 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $21,337,029 | 237,712 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,892,374 | 290,434 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,625,532 | 260,880 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $34,488,699 | 278,584 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $35,048,295 | 265,618 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $28,552,665 | 261,903 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $27,607,174 | 268,161 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $28,661,952 | 248,392 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,396,610 | 229,313 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $24,501,310 | 220,832 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $11,917,113 | 138,378 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,841,717 | 64,075 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,793,001 | 82,791 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,420,897 | 96,828 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,845,750 | 91,143 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $4,562,610 | 58,668 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $4,343,252 | 56,340 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,307,177 | 52,655 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,536,869 | 54,694 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,117,624 | 66,179 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $1,996,207 | 25,945 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||